Efficacy, residual effectiveness and safety of diacerein in the treatment of knee osteoarthritis: A meta-analysis of randomized placebo-controlled trials

Abstract

Background: Osteoarthritis (OA) is the leading cause of disability in the elderly. Prevention and treatment of OA have become an urgent global demand. The pharmacologic role of diacerein in the treatment of osteoarthritis is controversial. We systematically reviewed the efficacy, safety, and residual effectiveness of diacerein.Objectives: To estimate the symptomatic efficacy, residual effect and safety of diacerein in the treatment of knee osteoarthritis, using a meta-analysis of published randomized controlled trials (RCTs).Methods: On December 1, 2021, we searched PubMed Medline, Web of Science, Cochrane Library databases, Wan Fang Medical Database, and National Knowledge Infrastructure. This study followed the inclusion criteria of the principle P(Population), I(Intervention), C(Comparison), O(Outcome), S (Study design) principle. All studies were randomized controlled trials of knee osteoarthritis. Cochrane bias risk assessment tool was used to assess the risk of bias. Meta-analyses were performed using a random-effects model. To explore sources of heterogeneity, subgroup analysis, sensitivity analysis, regression analysis and publication bias analysis were performed. Drug side effects with complete data were extracted from the included articles and then a combined analysis of these data was performed.Results: Eight studies were eligible and were included in our analysis (N = 1277 participants). All studies were randomized controlled trials of knee osteoarthritis. There was no significant difference in reduction of joint pain and improvement of function between diacerein and the control group. However, subgroup analysis suggested, compared with the placebo group, diacerein treatment yielded an improved mean reduction in visual analogue scale score of-0.44% (95% confidence interval [CI]-0.79 to 0.09), an improved the western Ontario and McMaster universities (physical function) score of -0.44% (95% CI-0.72 to -0.12). Follow-up analysis after discontinuation showed that diacerein treatment had a significant residual effect (95% CI-0.81 to-0.24). Data on drug side effects described in the included articles were extracted for statistical analysis. There was an increased risk of diarrhea with diacerein (Risk Ratio [RR] = 1.95 [1.03 to 2.47]) and withdrawal event from therapy (RR = 0.93 [0.75 to 1.15]).Conclusion: Diacerein might be considered an effective drug for the treatment of patients with KOA, showing short-term residual effectiveness. Although it is associated with an increased risk of diarrhea, the adverse event is mostly tolerable.Abbreviations: CI = confidence interval, NSAIDs = Non-steroidal anti-inflammatory drugs, OA = osteoarthritis, RCT = randomized controlled trial, RR = Risk Ratio, SMD = standardized mean difference, VAS = visual analogue scale, WOMAC = the western Ontario and McMaster universities.

Exploration of diacerein as a neuroprotective adjuvant to Adenium obesum: An in-vivo study

“…In the present study diacerein is used to treat the neuroinflammation & to enhance the efficiency of the A. obesum extract. Diacerein is a potent anti-inflammatory agent used to get relief in osteoarthritis it inhibits interleukin-1beta which is also a key player of neuroinflammation [ 37 ].…”

The Effects of the Combination of Rhein and Platelet-Rich Plasma on Human Articular Chondrocytes

“…Rhein has been also credited with different biological properties, including anti-inflammatory and chondroprotective activities [ 10 ]. Diacerein can improve pain and joint function, but its oral administration is associated with gastrointestinal secondary effects [ 11 ].…”

Effectiveness of Diacerein in Primary Knee Osteoarthritis

“…The existing data highlights benefits of diacerein to be small to be clinically significant which warrants further research. 8 There is no gold standard treatment for KOA so far. Usually, structure modifying or disease modifying agents are used in its treatment.…”